Large Caps with Small Differences


More capital by far goes into large cap ETFs than any other asset class. Subtle differences are magnified by the sheer size of positions in most portfolios, so it pays for investors to examine large cap ETFs closely.SPDR S&P 500 (AMEX:SPY - News) handles an astounding $91 Billion, while iShares S&P 500 ETF (NYSEArca:IVV - News) runs $27 Billion. These two funds alone account for about 10% of all ETF assets. Both charge a paltry 0.09% in annual fees.The main decision by large cap investors is whether to follow the popular S&P 500 format. One alternative is Vanguard's Large Cap ETF (NYSEArca:VV - News), with 0.12% fees. It follows the MSCI US Prime Market 750 Index, which throws some mid-sized companies into the mix. SPDR Dow Jones Wilshire Large Cap ETF (AMEX:ELR - News) also follows about 750 companies at 0.23% annual cost. The main attraction of these is to avoid fallout from additions and deletions to the S&P 500, which can cause a stock to swing as index funds buy or sell it. Arbitrageurs commonly jump ahead of these trades, always to the detriment of the funds.In practice, large cap ETF returns correlate heavily:

View photo

For buy-and-holders investors, Vanguard's VV and IVV are the clear choice due to low expenses. For investors cycling in and out at least once a year, S&P's SPY is superior because its huge size drives bid-ask spreads down to minute levels, saving investors money. With options this liquidity advantage is even more pronounced.Clearly large cap ETFs are a bet on the US economy, and by Summer of 2011 it was clear that the recovery was slowing down. Q1 GDP growth slowed to an annualized 1.8% rate, and analysts downgraded corporate earnings forecasts. Goldman Sachs, for instance, revised its S&P 500 forecast to 10% in 2011 and 8% in 2012. It expected profit margins to peak in 2011, but predicted earnings would continue to rise.There are other ways to constrain or stretch the large cap definition. The iShares S&P 100 ETF (NYSEArca:OEF - News) targets only mega-cap companies, while the iShares Russell 1000 ETF (NYSEArca:IWB - News) takes in some mid-cap firms. Larger firms are far more likely to have international subsidiaries earning foreign currency than smaller ones, so they have an inherent currency hedge against a falling dollar. Also, the largest firms tend to diversify their exposure to other economies and should suffer less from US debt woes. By the same token, they are less likely to benefit from a sharp upswing in the US economy as smaller, more domestic-oriented firms. Picking the appropriate ETF is a matter of judging the current state of economic cycles.Low fees are always welcome, and over time even a modest difference adds up. For example, an extra 0.10% annually will lower returns about 1.3% after ten years, all else being equal. It is enough to start taking notice if a substantial portion of a portfolio is deployed to large cap.Other ETF plays on large cap include various using fundamental financial ratios to filter out and select companies deemed to be more attractive:
  • PowerShares Dynamic Large Cap Growth Portfolio ETF (AMEX: PWB - News); 0.6% annual fees
  • PowerShares Dynamic Large Cap Portfolio ETF (AMEX:PJF - News); 0.6% annual fees
  • PowerShares Dynamic Large Cap Value ETF (AMEX:PWV - News); 0.6% annual fees
  • RevenueShares Large Cap ETF (NYSEArca:RWL - News); 0.54% fees
  • WisdomTree LargeCap Dividend ETF (NYSEArca :DLN - News); 0.28% fees
  • ELEMENTS SPECTRUM Large Cap US Sector ETN (NYSEArca:EEH - News); 0.75% fees
  • First Trust Large Cap Core AlphaDEX ETF (NYSEArca:FEX - News); 0.7% fees
There are also some large cap ETFs which allow for style investing, or weighting towards growth or value:
  • SPDR Dow Jones Wilshire Large Cap Growth ETF (AMEX:ELG - News); 0.2% fees
  • SPDR Dow Jones Wilshire Large Cap Value ETF (AMEX:ELV - News); 0.2% fees
  • iShares Morningstar Large Core ETF (NYSEArca:JKD - News); 0.2% fees
  • iShares Morningstar Large Growth ETF (NYSEArca:JKE - News); 0.25% fees
  • iShares Morningstar Large Value ETF (NYSEArca:JKF - News); 0.25% fees
  • Then there are ETFs which combine fundamental and style investing:
  • Claymore Great Companies Large-Cap Growth ETF (AMEX:XGC - News); 0.6%
  • ELEMENTS Benjamin Graham Large Cap Value Total Return ETN (NYSEArca:BVL - News); 0.75%
  • First Trust Large Cap Growth Opportunities AlphaDEX ETF (NYSEArca:FTC - News); 0.7%
  • First Trust Large Cap Value Opportunities AlphaDEX ETF (NYSEArca:FTA - News); 0.7%
  • Grail American Beacon Large Cap Value ETF (NYSEArca:GVT - News); 0.79%
  • Wisdom Tree Large Cap Growth ETF (NYSEArca: ROI - News); 0.38%
Finally there are the traders' vehicles, suitable only for speculative bets over short time periods:
  • Direxion Large Cap Bear 3x Shares ETF (NYSEArca:BGZ - News); 0.95%
  • Direxion Large Cap Bull 3x Shares ETF (NYSEArca:BGU - News); 0.95%
Co-founder of, author of two books on investing, and founder of, Will has been writing on indexing issues for 8 years. He holds an MBA from the University of Texas at Austin.


View Comments (0)

Recommended for You

  • Apple's iPhone sales beat Street but iPad volumes slide

    Apple Inc (AAPL.O) forecast a strong holiday quarter after a better-than-expected 16 percent jump in iPhone sales, and the strongest growth in Mac computer shipments in years helped the company surpass Wall Street's targets. The company on Monday projected stronger-than-expected revenue of $63.5 billion to $66.5 billion in the December quarter, when new iPads and iPhones vie with rival devices from Microsoft Corp (MSFT.O) and Inc (AMZN.O) for consumers' holiday outlays. Shares of Apple rose 1.3 percent to about $101.10 in after-hours trade. A gradual decline in tablet demand worldwide has worried investors already concerned with Apple's slowing growth, who are awaiting a new device that can energize its expansion.

    7 mins ago
  • Often Overlooked Method to Pay Off Mortgage

    If you own a home and pay for a mortgage, you could reduce your payments by an average of $4,100 a year. Here is how it works.

  • Asian share gains fade as China data fail to temper growth anxiety

    China's gross national product expanded 7.3 percent between July and September from a year earlier, slightly above expectations but slower than the 7.5 percent clocked in the second quarter. It was also the weakest growth rate in nearly six years, putting at risk Bejing's official annual growth target for the first time in 15 years and adding to worries that China is becoming a drag on the global economy.

    7 mins ago
  • China posts slowest growth since global crisis, more stimulus expected

    China's economic growth slowed in the third quarter to its weakest since the 2008/09 global financial crisis as a slumping property market dragged on manufacturing and investment, adding to concerns about flagging global growth. The slowdown reinforced expectations that Beijing will need to unveil more stimulus measures to avert a sharper slowdown, though analysts appeared divided over whether policymakers would continue to roll out more modest support steps or take more aggressive action such as cutting interest rates. The weaker gross domestic product figure fed speculation that China will miss its official full-year growth target of 7.5 percent, even though Premier Li Keqiang has stated repeatedly that the country can tolerate slightly lower growth. Li has instead indicated that the leadership's bottom line is maintaining robust employment levels to ward off social unrest, a policy priority for China's stability-obsessed Communist government.

    7 mins ago
  • Staples says probing possible payment card data breach

    "Staples is in the process of investigating a potential issue involving credit card data and has contacted law enforcement," company spokesman Mark Cautela said in a statement late Monday. The office-supply retailer disclosed the investigation after security reporter Brian Krebs reported on his blog that several banks have identified a pattern of payment card fraud suggesting that several Staples stores in northeastern United States had succumbed to a data breach.

    7 mins ago
  • Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant

    Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was making a hostile takeover bid, court documents showed. Ackman's hedge fund has been working with Valeant for months to craft a deal for Valeant to buy Allergan, but Allergan has rejected all of Valeant's overtures and tried to find other potential partners to avoid a deal. In the filing with the federal court in Santa Ana, California, lawyers said that Pyott provided false and misleading information about Valeant to investors, failed to disclose Allergan CFO Jeff Edward's resignation in a timely manner, and ignored outside advisors' input when he falsely called Valeant's account "opaque" and "problematic."

    7 mins ago
  • China must accelerate reforms, not rely on fiscal and monetary policy to drive growth: World Bank

    China needs to accelerate reforms and not rely solely on monetary and fiscal policy to drive growth, a top World Bank official said on Tuesday. "I would recommend not really relying more on their macro policy, specifically on the monetary and fiscal side, because it's been done before, especially post the global financial crisis," Managing Director Sri Mulyani Indrawati told Reuters in an interview in Beijing. Indrawati made the comments when asked whether China was reforming fast enough, given that the country posted its weakest economic growth rate in the third quarter since the 2008/09 global financial crisis.

    7 mins ago
  • AbbVie says $55 billion acquisition of Shire officially dead

    AbbVie, which last week said its board of directors had withdrawn its recommendation to proceed with the Shire purchase, blamed the unraveling on last month's rules changes by the U.S. The company's Chief Executive, Richard Gonzalez, on a conference call with investors, said the new rules and possible future changes "created an environment of risk and uncertainty which makes proceeding not in the best interest of our shareholders." In addition to tax benefits, the acquisition would have given AbbVie Shire's portfolio of lucrative medicines for rare diseases and other specialty drugs, lessening the Chicago-based company's dependence on its rheumatoid arthritis treatment Humira - currently the world's top selling drug with annual sales approaching $13 billion.

    7 mins ago
  • The New Sedan that Stands out from the Crowd

    Incredible driving with incredible fuel efficiency is now a reality. New 2015 Models have just arrived! Search online for dealer inventory.

    AdChoicesMazda USASponsored
  • Valeant says may raise Allergan bid; beats on profit

    Valeant CEO Michael Pearson said a possible revised stock and cash bid would be worth more than $200 per share, assuming that Valeant's stock rises, and would include more cash. Allergan stock was up 1.7 percent at $180.45. Valeant's third-quarter results were keenly anticipated for their potential impact on Valeant's bid for Allergan, maker of anti-wrinkle injection Botox. Unlike most quarters in which, according to critics, one-time charges related to acquisitions obscure Valeant's performance, the company made few deals as it stalked Allergan.

    7 mins ago
  • China to pitch high-speed trains to California

    State-backed China CNR Corporation is making a pitch to sell its high-speed trains to California, signaling China's growing export ambitions for such technology after building the world's longest network in just seven years. It marks the first concrete attempt by China to sell high-speed locomotives abroad and establish itself as a credible rival to sector leaders such as Germany's Siemens, Canada's Bombardier and Japan's Kawasaki. CNR, its unit Tangshan Railway and U.S.-based SunGroup USA are submitting an expression of interest to California's $68 billion high-speed rail project for a contract to supply up to 95 trains that can travel as fast as 354 kilometers per hour (221 miles per hour), SunGroup told Reuters. "We believe that high-speed rail is something that China does very well, and it's a product that we can export across the world," SunGroup spokesman Jonathan Sun said in a phone interview, adding that SunGroup, CNR and Tangshan Railway had been working together for four years.

    8 mins ago
  • Top Allergan holder Paulson urges deal with Shire: sources

    The hedge fund, which earlier supported a deal with Valeant, told Allergan CEO David Pyott that it would now support a deal with Shire, the sources said. It was not immediately clear whether Allergan would pursue such a deal. Paulson had a 1.9 percent stake in Allergan, making it one of the company's top 10 shareholders, according to Thomson Reuters data as of June 30. Paulson was also Shire's third-largest shareholder, according to the data.

    8 mins ago